The Tailored Biosimilar Approach: Expectations and Requirements [PDF]
Elena Guillén +11 more
openalex +1 more source
Understanding the market dynamics of biosimilars
, 2016 Biosimilars represent an attractive market opportunity in the pharmaceutical industry. In order to understand the underlying market dynamics and to identify the success factors of the biosimilars market, a PEST (political, economic, social, technological)
Dassow, J. (Jonas) +3 more
core
Reviews Brand-name drug, generic drug, orphan drug. Pharmacological therapy with biosimilar drugs – provision of due diligence in the treatment process [PDF]
, 2013 Justyna Zajdel, Radosław Zajdel
openalex +1 more source
RGB-02 (Biosimilar Pegfilgrastim) In The Treatment Of Chemotherapy-Induced Neutropenia
, 2019 Dóra Sántha +4 more
openalex +1 more source
Generics, Biosimilars, and the Ethics of Pricing Pharmaceuticals [PDF]
, 2016 Mark A. Brown
openalex +1 more source
Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump [PDF]
, 2018 James Thrasher +6 more
openalex +1 more source
Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities [PDF]
, 2021 Hasumati Rahalkar +6 more
openalex +1 more source
Patienten vor einem „Switch“ auf ein Biosimilar umfassend aufklären [PDF]
, 2019 G Bakalos, C Gasteiger
openalex +1 more source
Biosimilars in Rheumatology: General Issues
, 2015 José M. Serra López-Matencio +1 more
openalex +1 more source
Creating China’s Biosimilar Drugs Regulatory System: A Calculated Approach [PDF]
, 2022 Jianhong Yang +9 more
openalex +1 more source